ciprofloxacin has been researched along with Pelvic Pain in 8 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
Pelvic Pain: Pain in the pelvic region of genital and non-genital origin.
Excerpt | Relevance | Reference |
---|---|---|
" To explore the potential therapeutic benefit of roxithromycin in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), this study compared the effect of roxithromycin with ciprofloxacin and aceclofenac." | 9.19 | Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial. ( Cho, YH; Choe, HS; Han, CH; Lee, SJ; Shim, BS, 2014) |
"To investigate the value of Tc-99m ciprofloxacin imaging in the differential diagnosis of chronic bacterial prostatitis." | 9.10 | Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis. ( Choe, W; Kim, S; Lee, SM; Moon, Y; Pai, SH; Ryu, JK; Seong, DW; Suh, JK, 2003) |
" To explore the potential therapeutic benefit of roxithromycin in chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS), this study compared the effect of roxithromycin with ciprofloxacin and aceclofenac." | 5.19 | Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial. ( Cho, YH; Choe, HS; Han, CH; Lee, SJ; Shim, BS, 2014) |
"To investigate the value of Tc-99m ciprofloxacin imaging in the differential diagnosis of chronic bacterial prostatitis." | 5.10 | Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis. ( Choe, W; Kim, S; Lee, SM; Moon, Y; Pai, SH; Ryu, JK; Seong, DW; Suh, JK, 2003) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 6 (75.00) | 29.6817 |
2010's | 2 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Choe, HS | 1 |
Lee, SJ | 1 |
Han, CH | 1 |
Shim, BS | 1 |
Cho, YH | 1 |
Brueseke, TJ | 1 |
Lane, FL | 1 |
Ryu, JK | 1 |
Lee, SM | 1 |
Seong, DW | 1 |
Suh, JK | 1 |
Kim, S | 1 |
Choe, W | 1 |
Moon, Y | 1 |
Pai, SH | 1 |
Alexander, RB | 2 |
Propert, KJ | 2 |
Schaeffer, AJ | 2 |
Landis, JR | 2 |
Nickel, JC | 2 |
O'Leary, MP | 1 |
Pontari, MA | 1 |
McNaughton-Collins, M | 1 |
Shoskes, DA | 1 |
Comiter, CV | 1 |
Datta, NS | 1 |
Fowler, JE | 1 |
Nadler, RB | 1 |
Zeitlin, SI | 1 |
Knauss, JS | 1 |
Wang, Y | 1 |
Kusek, JW | 2 |
Nyberg, LM | 2 |
Litwin, MS | 2 |
Weidner, W | 1 |
Kulovac, B | 1 |
Aganović, D | 1 |
Prcić, A | 1 |
Hadziosmanović, O | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
[NCT01843946] | 75 participants (Actual) | Observational | 2011-03-31 | Completed | |||
A Randomized Clinical Trial to Evaluate the Efficacy and Safety of 10mg Alfuzosin in the Treatment of Chronic Prostatitis / Chronic Pelvic Pain Syndrome (CP/CPPS) in Recently-Diagnosed and/or Newly-Symptomatic Alpha-blocker Naïve Patients[NCT00103402] | Phase 3 | 272 participants (Actual) | Interventional | 2005-02-28 | Completed | ||
Ciprofloxacin or Tamsulosin in Men With Chronic Prostatitis/Chronic Pelvic Pain Syndrome: a Randomized, Double-blind Trial[NCT04552431] | Phase 2 | 196 participants (Actual) | Interventional | 1997-09-30 | Completed | ||
Genetic Study of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)[NCT00499317] | 500 participants (Anticipated) | Observational | 2007-01-15 | Recruiting | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
For the Hospital Anxiety and Depression Scale, higher scores indicate greater anxiety and depression; range, 0 to 42. (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | units on a scale (Mean) |
---|---|
Alfuzosin | -2.6 |
Placebo | -1.5 |
For the International Index of Erectile Function, higher scores indicate better sexual function; range, 0 to 75. (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | units on a scale (Mean) |
---|---|
Alfuzosin | 0.5 |
Placebo | -0.2 |
For the Male Sexual Health Questionnaire, higher scores indicate better function with respect to erection and ejaculation and greater satisfaction with sexual life; range, 0 to 40. (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | units on a scale (Mean) |
---|---|
Alfuzosin | 1.7 |
Placebo | 0.6 |
For the National Institutes of Health Chronic Prostatitis Symptom Index (NIHCPSI) total score, higher scores indicate more severe symptoms and scores range from 0 to 43. The primary outcome was a decline of at least 4 from baseline to 12 weeks (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | Participants (Count of Participants) |
---|---|
Alfuzosin | 68 |
Placebo | 66 |
For the Medical Outcomes Study Short Form Health Survey 12 (SF-12), higher scores indicate better quality of life. Score range for both the physical and mental component summaries is 0 to 100. (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | units on a scale (Mean) | |
---|---|---|
Physical component | Mental component | |
Alfuzosin | 3.0 | 4.0 |
Placebo | 3.5 | 1.9 |
For the McGill Pain Questionnaire, higher scores indicate greater pain. Score ranges are as follows: total score, 0 to 45; sensory score, 0 to 33; affective score, 0 to 12. (NCT00103402)
Timeframe: Baseline and 12 weeks
Intervention | units on a scale (Mean) | ||
---|---|---|---|
Total score | Sensory score | Affective score | |
Alfuzosin | -3.4 | -2.5 | -1.0 |
Placebo | -3.1 | -2.3 | -0.9 |
For the National Institutes of Health Chronic Prostatitis Symptom Index (NIHCPSI), higher scores indicate more severe symptoms (for the quality-of-life score, higher scores indicate a more negative effect). Score ranges are as follows: total score, 0 to 43; pain score, 0 to 21; urinary score, 0 to 10, quality-of-life score, 0 to 12; and average pain and urgency scores, 0 to 10. (NCT00103402)
Timeframe: Baseline and12 weeks
Intervention | units on a scale (Mean) | |||
---|---|---|---|---|
Total score | Pain score | Urinary score | Quality-of-life score | |
Alfuzosin | -7.1 | -3.3 | -1.2 | -1.2 |
Placebo | -6.5 | -3.0 | -1.0 | -1.2 |
5 trials available for ciprofloxacin and Pelvic Pain
Article | Year |
---|---|
Clinical efficacy of roxithromycin in men with chronic prostatitis/chronic pelvic pain syndrome in comparison with ciprofloxacin and aceclofenac: a prospective, randomized, multicenter pilot trial.
Topics: Adult; Chronic Disease; Ciprofloxacin; Diclofenac; Humans; Male; Pelvic Pain; Pilot Projects; Prospe | 2014 |
Tc-99m ciprofloxacin imaging in diagnosis of chronic bacterial prostatitis.
Topics: Adult; Aged; Bacterial Infections; Chronic Disease; Ciprofloxacin; Humans; Male; Middle Aged; Organo | 2003 |
Ciprofloxacin or tamsulosin in men with chronic prostatitis/chronic pelvic pain syndrome: a randomized, double-blind trial.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-B | 2004 |
Management of chronic nonbacterial prostatitis/chronic pelvic pain syndrome.
Topics: Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Doxazosin; Drug Therapy, Combination; | 2007 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
Design of a multicenter randomized clinical trial for chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Drug Therapy, C | 2002 |
3 other studies available for ciprofloxacin and Pelvic Pain
Article | Year |
---|---|
Ischiorectal fossa abscess after pelvic floor injection of botulinum toxin.
Topics: Abscess; Ampicillin; Anti-Bacterial Agents; Anti-Dyskinesia Agents; Anus Diseases; Botulinum Toxins; | 2012 |
Summaries for patients. Treating men with chronic prostatitis/chronic pelvic pain syndrome.
Topics: Adrenergic alpha-Antagonists; Adult; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Double-B | 2004 |
Treating chronic prostatitis: antibiotics no, alpha-blockers maybe.
Topics: Adrenergic alpha-Antagonists; Anti-Infective Agents; Chronic Disease; Ciprofloxacin; Humans; Male; P | 2004 |